A 150-Year-Old Drug Could Improve One of the Biggest Problems with Radiation Therapy.New research suggests that the drug, called papaverine, could give a much-needed boost to radiation therapy, increasing its impact on cancerous cells in hard-to-reach areas.

See the source article by following the link below:
A 150-Year-Old Drug Could Improve One of the Biggest Problems with Radiation Therapy.New research suggests that the drug, called papaverine, could give a much-needed boost to radiation therapy, increasing its impact on cancerous cells in hard-to-reach areas.